Stroke and recurrent pregnancy loss due to hyperhomocysteinaemia.
Igor
Sibon
S
Guilhem
Sole
S
Isabelle
Redonnet-Vernet
RV
D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2) / Q000235:genetics; D000026:Abortion, Habitual / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D001921:Brain / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000235:genetics / Q000503:physiopathology; D020244:Infarction, Middle Cerebral Artery / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D009154:Mutation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D020521:Stroke / Q000097:blood / Q000209:etiology* / Q000473:pathology*; D016896:Treatment Outcome; D014805:Vitamin B 12 / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D006710:Homocysteine; D005492:Folic Acid; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D014805:Vitamin B 12